Failure to Confirm a Prolongation of the Biological Half-Life of 22Na in Hypertensive Patients

Circulation Research - United States
doi 10.1161/01.res.19.4.750
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Plasma Half-Life of Clofibric Acid in Renal Failure.

British Journal of Clinical Pharmacology
Pharmacology
1979English

The Prolongation of Human Life.

The Lancet
Medicine
1927English

The Measurement of Quality of Life in Hypertensive Patients: A Practical Approach.

British Journal of Clinical Pharmacology
Pharmacology
1990English

Prevalence, Predictors, and Prognostic Implications of PR Interval Prolongation in Patients With Heart Failure

Clinical Research in Cardiology
MedicineCardiovascular MedicineCardiology
2017English

Studies on the Half-Life of C-Terminal Parathyroid Hormone in Chronic Renal Failure

Folia Endocrinologica Japonica
1987English

Quality of Life in Patients With Heart Failure: Ask the Patients

Heart and Lung: Journal of Acute and Critical Care
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

PEPlife: A Repository of the Half-Life of Peptides

Scientific Reports
Multidisciplinary
2016English

The Effects of Carvedilol, a Vasodilating ^|^beta;-Adrenoceptor Blocker, on the Quality of Life in Hypertensive Patients

Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
1999English

Editorial: Real-Life Data Confirm Efficacy of Elbasvir/Grazoprevir in HCV Patients With Severe Kidney Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy